Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Biolife Solutions Inc shares valued at $529,150 were sold by Mathew Aby J. on Nov 15 ’24. At $21.17 per share, Mathew Aby J. sold 25,000 shares. The insider’s holdings dropped to 302,046 shares worth approximately $7.55 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Mathew Aby J. sold 17,604 shares, netting a total of over 352,960 in proceeds. Following the sale of shares at $20.05 each, the insider now holds 284,442 shares.
Before that, Berard Todd had sold 91 shares from its account. In a trade valued at $2,397, the Chief Marketing Officer traded Biolife Solutions Inc shares for $26.34 each. Upon closing the transaction, the insider’s holdings decreased to 91 shares, worth approximately $2.69 million.
As published in their initiating research note from H.C. Wainwright on September 30, 2024, Biolife Solutions Inc [BLFS] has been a Buy and the price target has been revised to $29. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in early April. As of July 11, 2023, Craig Hallum has initiated its “Buy” rating for BLFS. Earlier on April 25, 2022, Oppenheimer upgraded its rating. Their new recommendation was “an Outperform” for BLFS stock which previously was a “a Perform”.
Analyzing BLFS Stock Performance
During the last five days, there has been a surge of approximately 3.73%. Over the course of the year, Biolife Solutions Inc shares have jumped approximately 53.91%. Shares of the company reached a 52-week high of $28.88 on 11/13/24 and a 52-week low of $14.50 on 03/01/24. A 50-day SMA is recorded $23.96, while a 200-day SMA reached $21.25. Nevertheless, trading volume fell to 0.93 million shares from 0.71 million shares the previous day.
Support And Resistance Levels for Biolife Solutions Inc (BLFS)
According to the 24-hour chart, there is a support level at 22.90, which, if violated, would cause prices to drop to 20.80. In the upper region, resistance lies at 26.11. The next price resistance is at 27.22. RSI (Relative Strength Index) is 54.75 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.80, which suggests the price will decrease in the coming days. Percent R is at 41.13%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
